Drouet L, Mazoyer E, Bal dit Sollier C, Hainaud P, Ripoll L
Service d'angio-hématologie, hôpital Lariboisière, Paris.
Arch Mal Coeur Vaiss. 1998 Oct;91 Spec No 5:41-51.
The factors of thrombosis (endothelium, haemostasis, coagulation, fibrinolysis) are implicated from the initiating phase of atherosclerotic lesions. Their participation is more established (and studied) in the later phases of intraluminal evolution of atherosclerosis, of thromboembolic complications of the lesions and interventional procedures. The traditional theory of response to physical lesions of the endothelium as an initiating factor of atherosclerotic lesions, which gave platelets an essential role, has been replaced by that linking an early functional lesion of the endothelium and a cellular response by monocytes infiltrating the vessel wall, becoming macrophages. The macrophages participate in changes of the LDL in the wall, ingest the lipids at the same time as the smooth muscle cells which have migrated and proliferated from the media to the intima. The lipid overload, especially with oxidised LDL, is intracellular at first in these foam cells, then extracellular as the cells die. During the early stages, all the tissue factors of activation and development of coagulation are present in the vessel wall and then within the lesion. This intra-cellular coagulation results in the production of thrombi in the tissues and the transformation of fibrinogen to fibrin. These stages precede and participate in cellular proliferation and extracellular lipid deposits. Factors of tissular thrombolysis (the uPA pathway) play a part in cellular immigration and proliferation. It is only at a later stage that the lesion activates intravascular coagulation and fibrinolysis which, in conditions of variable equilibrium, will result in the clinical complications of the atherosclerotic process. All these factors therefore participate firstly in the tissues and then within the lumen, in the progression and complications of atherosclerosis which for these reasons is often called atherothrombotic disease. The comprehension of these mechanisms is essential for the development and interpretation of tests and treatment applied to different stages of the disease, which is all the more complex given that in a given patient at a given time, lesions at different stages are present in the arterial network.
血栓形成的因素(内皮、止血、凝血、纤维蛋白溶解)在动脉粥样硬化病变的起始阶段就有涉及。它们在动脉粥样硬化管腔内演变的后期阶段、病变的血栓栓塞并发症以及介入操作中发挥着更为明确(且被研究)的作用。传统理论认为内皮对物理损伤的反应是动脉粥样硬化病变的起始因素,血小板在其中起关键作用,如今这一理论已被新理论取代,新理论将早期内皮功能损伤与单核细胞浸润血管壁并转变为巨噬细胞的细胞反应联系起来。巨噬细胞参与血管壁内低密度脂蛋白(LDL)的变化,与从血管中膜迁移并增殖至内膜的平滑肌细胞同时摄取脂质。脂质过载,尤其是氧化型LDL,最初在这些泡沫细胞内,细胞死亡后则在细胞外。在早期阶段,血管壁以及随后的病变部位存在所有参与凝血激活和发展的组织因子。这种细胞内凝血导致组织内血栓形成以及纤维蛋白原转化为纤维蛋白。这些阶段先于细胞增殖和细胞外脂质沉积并参与其中。组织纤溶因子(尿激酶型纤溶酶原激活物途径)在细胞迁移和增殖中发挥作用。只有在后期,病变才激活血管内凝血和纤维蛋白溶解,在可变的平衡状态下,这将导致动脉粥样硬化过程的临床并发症。因此,所有这些因素首先在组织内,然后在管腔内参与动脉粥样硬化的进展和并发症,正因如此,动脉粥样硬化常被称为动脉粥样硬化血栓形成性疾病。理解这些机制对于开发和解释针对该疾病不同阶段的检测方法和治疗手段至关重要,鉴于在特定时间的特定患者中,动脉网络中存在不同阶段的病变,这使得情况更加复杂。